Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/22/2011 | EP2336313A1 Methods for production of proteins |
06/22/2011 | EP2336312A1 Triterpene oxidase derived from glychyrrhiza plant, gene encoding the oxidase, and method for utilizing the gene |
06/22/2011 | EP2336311A1 Anti-tuna vasa antibody |
06/22/2011 | EP2336309A2 Polypeptides having endoglucanase activity and polynucleotides encoding same |
06/22/2011 | EP2336303A1 NKT CELL-DERIVED iPS CELLS AND NKT CELLS DERIVED THEREFROM |
06/22/2011 | EP2336302A1 Nucleotide sequence encoding the enzyme I-sceI and the uses thereof |
06/22/2011 | EP2336301A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
06/22/2011 | EP2336300A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
06/22/2011 | EP2336299A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
06/22/2011 | EP2336298A2 Postpartum cells derived from placental tissue and methods of making and using the same |
06/22/2011 | EP2336297A2 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
06/22/2011 | EP2336190A2 Anti-VEGF antibodies |
06/22/2011 | EP2336187A2 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
06/22/2011 | EP2336186A1 Humanized antibodies against ICAM-1, their production and uses |
06/22/2011 | EP2336185A1 Anti- alpha v beta 6 antibodies |
06/22/2011 | EP2336176A1 Antibodies directed against hepatitis c virus e1e2 complex, and their epitopes |
06/22/2011 | EP2336175A1 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
06/22/2011 | EP2336169A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
06/22/2011 | EP2336168A1 Novel protein and method for producing the protein |
06/22/2011 | EP2336167A1 MHC molecule constructs and their uses for diagnosis and therapy |
06/22/2011 | EP2335728A1 Specific binding proteins and uses thereof |
06/22/2011 | EP2335726A1 Fusion molecules and methods for treatment of immune diseases |
06/22/2011 | EP2335720A1 Autologous T-cell vaccines materials and methods |
06/22/2011 | EP2335712A2 Composition for preventing or treating liver diseases, containing plant stem cell lines derived from the cambium of panax ginseng including mountain ginseng or ginseng as active ingredient |
06/22/2011 | EP2335650A1 Particulate cartilage system |
06/22/2011 | EP2334804A2 Co-culture compositions and methods |
06/22/2011 | EP2334798A2 Glutamate decarboxylase (gad) transgenic plants that exhibit altered plant architecture |
06/22/2011 | EP2334787A1 Method of correlating marker molecule concentration to a specific cell potency level in chondrocyte culture |
06/22/2011 | EP2334786A2 Isolation and identification of glycosaminoglycans |
06/22/2011 | EP2334785A2 Compositions containing platelet contents |
06/22/2011 | EP2334784A1 Use of hsa-producing cells |
06/22/2011 | EP2334783A2 Adherent cells from placenta tissue and use thereof in therapy |
06/22/2011 | EP2334696A1 G6pc2-encoded beta cell surface tags |
06/22/2011 | EP1999257B1 Polypeptides having endoglucanase activity and polynucleotides encoding same |
06/22/2011 | EP1987137B1 Synthesis of sialic acid in plants |
06/22/2011 | EP1874921B1 Transplantation of differentiated immature adipocytes and biodegradable scaffold for tissue augmentation |
06/22/2011 | EP1836226B1 Antibodies against il-13 receptor alpha 1 and uses thereof |
06/22/2011 | EP1680503B1 Recombinant production of antimicrobial agents |
06/22/2011 | EP1546388B1 Real time measurement of cellular responses |
06/22/2011 | EP1546174B1 Methods and compositions for rna interference |
06/22/2011 | EP1419240B1 Production and use of human cd124 and cd116 positive tumour cell lines in the production of allogenic or semi-allogenic immunotherapy agents |
06/22/2011 | EP1328545B1 Human gene critical to fertility |
06/22/2011 | EP1290161B1 METHODS FOR MEDIATING GENE SUPPRESION BY USING FACTORS THAT ENHANCE RNAi |
06/22/2011 | EP1207876B1 Use of a modulator which acts on a growth factor precursor in order to inhibit growth factor precursor processing |
06/22/2011 | EP1204683B1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
06/22/2011 | CN1891714B Ligand for herpes simplex virus entry mediator and methods of use |
06/22/2011 | CN1447819B Human CYR 61 |
06/22/2011 | CN1405300B Cell with modified cell membrane |
06/22/2011 | CN1384885B Preparation method of recombinant adenoviruses and adenovirus banks |
06/22/2011 | CN102105789A Brown adipocyte progenitors in human skeletal muscle |
06/22/2011 | CN102105580A Treatment of pluripotent cells |
06/22/2011 | CN102105579A Isolation, characterization and propagation of germline stem cells |
06/22/2011 | CN102103141A Immunity-chromatography kit for rapid diagnosis of malaria and its pathogen species and preparation method thereof |
06/22/2011 | CN102102111A Method for synthesizing optically-active aryl vicinal diol under catalysis of plant cells |
06/22/2011 | CN102102106A Methods for modifying plant characteristics |
06/22/2011 | CN102102103A Experiment method for establishing an animal model for studying oral white sponge nevus of the Chinese |
06/22/2011 | CN102102094A Thermostable lipase, expression of coding gene of thermostable lipase and applications of thermostable lipase |
06/22/2011 | CN102102093A High temperature lipase, preparation for mutants thereof and application thereof |
06/22/2011 | CN102102091A C genotype entecavir-resistant mutation HBV stable replication and expression cell line |
06/22/2011 | CN102102090A Method for inducing in vitro directed differentiation of stem cells through non-contact coculture |
06/22/2011 | CN102102089A Method for establishing magnolia officinalis suspension culture system |
06/22/2011 | CN102101882A Plant low temperature stress resistance-related protein and encoding gene and application thereof |
06/22/2011 | CN102100925A Preparation method of novel injectable polypeptide hydrogel |
06/22/2011 | CN102100910A Method for producing viral vaccines |
06/22/2011 | CN101514340B Sequence and application of a promoter of a human autophagic gene beclin 1 |
06/22/2011 | CN101485342B Animal antifeedant prepared from protonema of Tortula muralis Hedw. cultivated with cell engineering |
06/22/2011 | CN101455179B Tissue culture method of aged Sinojackia xylocarpa |
06/22/2011 | CN101300343B Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same |
06/22/2011 | CN101148671B Spartina anglica sodium hydrogen pump protein gene SaNHX and application thereof |
06/21/2011 | US7964779 Celery cultivar ADS-18 |
06/21/2011 | US7964777 Soybean cultivar 7629164 |
06/21/2011 | US7964776 Soybean cultivar 72143110 |
06/21/2011 | US7964775 Soybean cultivar 76171112 |
06/21/2011 | US7964773 Of given amino acid sequence; transforming plants to be resistant to insects and larvae |
06/21/2011 | US7964772 Pea line 08270930 |
06/21/2011 | US7964769 Using vector transfromation to generate transgenic soybean seeds with enhanced concentrations of lipids, fatty acids, starches and storage proteins |
06/21/2011 | US7964768 Non-dehiscent sesame variety Sesaco 27 |
06/21/2011 | US7964713 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
06/21/2011 | US7964712 Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains |
06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
06/21/2011 | US7964578 Conjugates and compositions for cellular delivery |
06/21/2011 | US7964570 Administering a recombinant adeno-associated virus (rAAV) containing a transgene that encodes a protein MBNL1, MBNL2, or MBNL3 |
06/21/2011 | US7964555 Contacting cardiac muscle cells with a neuregulin protein to activate the MAP kinase pathway in cardiac muscle cells and induce remodeling of cardiac muscle cell sarcomeric and cytoskeleton structures or cell-cell adhesions |
06/21/2011 | US7964406 Means and methods for producing a stabilized cell of interest |
06/21/2011 | US7964405 Plant cultivation method |
06/21/2011 | US7964404 Methods for increasing germination vigor by early singulation of conifer somatic embryos |
06/21/2011 | US7964402 Methods for culture and production of single cell populations of human embryonic stem cells |
06/21/2011 | US7964401 Screening method for somatic cell nuclear reprogramming substance affecting ECAT2 and ECAT3 |
06/21/2011 | US7964400 Immune potentiating compositions of cancer cells |
06/21/2011 | US7964399 Nucleotide sequence vector that encodes a truncated Flk-1 protein which inhibits the binding of VEGF; uses for evaluate and screen of cancer drugs; as biodrug for modulating vasculogenesis and angiogenesis, inhibiting the tumor growth |
06/21/2011 | US7964398 Modified vaccinia ankara virus variant and cultivation method |
06/21/2011 | US7964397 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
06/21/2011 | US7964396 Modified vaccinia ankara virus variant and cultivation method |
06/21/2011 | US7964395 Modified vaccinia ankara virus variant and cultivation method |
06/21/2011 | US7964394 Spore-like cells and uses thereof |
06/21/2011 | US7964374 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
06/21/2011 | US7964346 Using avian cells as screening tools in monitoring and/or identifying viricidal agents |
06/21/2011 | US7963906 Imaging and evaluating embryos, oocytes, and stem cells |
06/21/2011 | CA2439857C Caloporoside derivatives, process for their preparation and their use |
06/21/2011 | CA2413316C Genetically modified plants with heterogeneous proteinase inhibitor sapin2a and methods of use thereof for the inhibition of endogenous trypsin-and chymotrypsin-like activities |